Equipmake Holdings - Director's Dealings

Announcement provided by

Equipmake Holdings PLC · EQIP

02/03/2026 07:01

RNS Number : 7989U

Equipmake Holdings PLC

02 March 2026

2 March 2026

Equipmake Holdings plc

("Equipmake" or the "Company")

Director's Dealings

Equipmake announces that it has been notified of the following acquisitions of ordinary shares in the Company undertaken by Tim Metcalfe, Non-Executive Chairman, and Jane Metcalfe, Mr. Metcalfe's wife, details of which are set out in the notification below.

Following these purchases, Mr and Mrs Metcalfe together hold 1,380,088 Ordinary Shares, representing approximately 0.12% of the Company's issued share capital.

Details of the person discharging managerial responsibilities / person closely associated

Name

Timothy Mark Metcalfe

Jane Susan Metcalfe

Reason for the Notification

Position/status

Director

Wife of Mr. Metcalfe

Initial notification / Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Equipmake Holdings plc

LEI

213800NY1WGJ26E4HB59

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.0001 each

Identification Code

GB00BMBVXB73

Nature of the transaction

Purchase of Ordinary Shares

Price(s) and volume(s)

	Price(s)	Volume(s)
1)	1.39 pence per Ordinary Share	359,712 Ordinary Shares
2)	1.39 pence per Ordinary Share	359,712 Ordinary Shares
3)	1.39 pence per Ordinary Share	251,798 Ordinary Shares

Aggregated information:

· Aggregated volume

· Price

971,222

£13,500

Date of the transaction

27 February 2026

Place of the Transaction

Aquis Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXZZGZZNNNGVZM]]>

EQIP announcements All announcements